U.S. Markets open in 8 hrs 54 mins

Akers Biosciences, Inc. (AKR.L)

London Stock Exchange - London Stock Exchange Delayed Price. Currency in GBp
Add to watchlist
75.00-5.00 (-6.25%)
At close: 4:30PM BST
People also watch
AMS.LAOR.LAGY.LAFN.LAGL.L
Full screen
Previous Close80.00
Open80.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range95.00 - 95.00
52 Week Range65.00 - 255.00
Volume287
Avg. Volume561
Market Cap6.64M
Beta-0.35
PE Ratio (TTM)-1.39
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • See what the IHS Markit Score report has to say about Akers Biosciences Inc.
    Markit6 days ago

    See what the IHS Markit Score report has to say about Akers Biosciences Inc.

    Short interest is low for AKER with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding AKER is favorable, with net inflows of $788 million.

  • IHS Markit Score Update: Drop in demand for ETFs holding Akers Biosciences Inc is a negative sign for its shares
    Markit13 days ago

    IHS Markit Score Update: Drop in demand for ETFs holding Akers Biosciences Inc is a negative sign for its shares

    Short interest is low for AKER with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The net inflows of $206 million over the last one-month into ETFs that hold AKER are among the lowest of the last year and appear to be slowing.

  • Akers Biosciences, Inc. :AKR-GB: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017
    Capital Cube2 months ago

    Akers Biosciences, Inc. :AKR-GB: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017

    Categories: Yahoo FinanceGet free summary analysis Akers Biosciences, Inc. reports financial results for the quarter ended March 31, 2017. Highlights Summary numbers: Revenues of GBP 0.54 million, Net Earnings of GBP -1.09 million. Gross margins narrowed from 67.10% to 54.81% compared to the same period last year, operating (EBITDA) margins now -195.04% from -197.89%. Change in operating ... Read more (Read more...)